Point72 Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-67,070
Closed -$149K 1370
2024
Q2
$149K Buy
67,070
+51,000
+317% +$113K ﹤0.01% 1038
2024
Q1
$43.1K Buy
16,070
+11,270
+235% +$30.2K ﹤0.01% 1352
2023
Q4
$14.4K Sell
4,800
-3,093,052
-100% -$9.25M ﹤0.01% 1314
2023
Q3
$3.04M Sell
3,097,852
-1,877,148
-38% -$1.84M 0.01% 783
2023
Q2
$6.92M Buy
4,975,000
+1,375,000
+38% +$1.91M 0.02% 590
2023
Q1
$5.72M Buy
3,600,000
+1,323,000
+58% +$2.1M 0.02% 621
2022
Q4
$14.2M Sell
2,277,000
-511,300
-18% -$3.19M 0.05% 412
2022
Q3
$18.7M Buy
2,788,300
+1,725,204
+162% +$11.6M 0.07% 325
2022
Q2
$6.76M Buy
+1,063,096
New +$6.76M 0.03% 546
2021
Q2
Sell
-648,200
Closed -$18.2M 969
2021
Q1
$18.2M Buy
+648,200
New +$18.2M 0.08% 273
2020
Q1
Sell
-4,800
Closed -$286K 828
2019
Q4
$286K Sell
4,800
-414,590
-99% -$24.7M ﹤0.01% 781
2019
Q3
$15.4M Buy
419,390
+352,617
+528% +$12.9M 0.09% 252
2019
Q2
$3.11M Sell
66,773
-150,327
-69% -$6.99M 0.02% 510
2019
Q1
$8.72M Buy
+217,100
New +$8.72M 0.04% 379
2018
Q4
Sell
-507,300
Closed -$22.5M 913
2018
Q3
$22.5M Buy
507,300
+143,200
+39% +$6.35M 0.09% 207
2018
Q2
$14.3M Buy
+364,100
New +$14.3M 0.06% 286
2015
Q4
Sell
-77,000
Closed -$1.82M 668
2015
Q3
$1.82M Buy
77,000
+38,200
+98% +$901K 0.01% 525
2015
Q2
$3.17M Buy
+38,800
New +$3.17M 0.02% 479
2015
Q1
Sell
-10,700
Closed -$433K 664
2014
Q4
$433K Buy
+10,700
New +$433K ﹤0.01% 576